Ljubomir Petrov

Cluj-napoca, CJ, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis.

Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis.

Journal: Journal of cancer research and clinical oncology

Published: March 15, 2017

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.

Journal: Journal of cancer research and clinical oncology

Published: January 25, 2017

Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania.

Transthoracic ultrasonography for the immunocompromised patient. A pilot project that introduces transthoracic ultrasonography for the follow-up of hematological patients in Romania.

Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne

Published: October 05, 2016

TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.

TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.

Journal: British journal of haematology

Published: December 06, 2015

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

Journal: Leukemia

Published: July 09, 2015

Non-Hodgkin lymphoma in Romania: a single-centre experience.

Non-Hodgkin lymphoma in Romania: a single-centre experience.

Journal: Hematological oncology

Published: May 27, 2015

Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo BMT.

Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo BMT.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: May 27, 2015

Cancer stem-like cells: the dark knights of clinical hematology and oncology.

Cancer stem-like cells: the dark knights of clinical hematology and oncology.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: June 27, 2014

Castleman Disease. A Report of Six Cases.

Castleman Disease. A Report of Six Cases.

Journal: Clujul medical (1957)

Published: January 01, 2014

Analysis of the MTHFR (methylenetetrahydrofolate reductase) 677 C>T and 1298 A>C polymorphisms in BCR-ABL-negative myeloproliferative neoplasms.

Analysis of the MTHFR (methylenetetrahydrofolate reductase) 677 C>T and 1298 A>C polymorphisms in BCR-ABL-negative myeloproliferative neoplasms.

Journal: International journal of laboratory hematology

Published: October 31, 2012

Absence of BRAF V600E mutation in a cohort of 402 patients with various chronic and acute myeloid neoplasms.

Absence of BRAF V600E mutation in a cohort of 402 patients with various chronic and acute myeloid neoplasms.

Journal: Leukemia & lymphoma

Published: February 21, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026